Michel de Baar

Venture Partner at Thuja Capital

Speaker

Michel is a biotech Investor who aims to connect exceptional science with the right strategy, partnership and investment. Before joining Thuja Capital in July 2026, he has enjoyed strong success in acquisitions, licensing, and research collaborations as BD&L Europe Lead at MSD. Prior to MSD he worked for various SMEs and Research Institutes, always following his passion to promote, and push for, innovative healthcare technologies that will become the medicines of tomorrow and improves patients' lives.